CIK 0000727510
- Non-accelerated filer
- Smaller reporting company
Viskase Holdings, Inc.
Sign in to watch- Ticker
- VISK
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 222372868
- Phone
- +1 630-874-0700
- Business address
- 333 EAST BUTTERFIELD ROAD, SUITE 400, LOMBARD, IL, 60148
- Former names
- ENZON PHARMACEUTICALS, INC., ENZON PHARMACEUTICALS INC, ENZON PHARMACEUTICALS INC, ENZON PHARMACEUTICAL INC, ENZON INC
- 4 Open-market sale EVP, R&D, CSO sold 101,329 shares at an average $9.30 ($942,578)
- 4 Grant or award EVP-Technical Operations acquired 12,665 shares (grant or award)
- 4 Grant or award Exec. Vice Pres. HR acquired 7,559 shares (grant or award)
- 4 Grant or award Exec VP Finance, CFO acquired 13,932 shares (grant or award)
- 4 Grant or award EVP,R&D, CSO acquired 16,465 shares (grant or award)
- 4 Grant or award CEO & President acquired 37,994 shares (grant or award)
- 4 Shares withheld for taxes EVP, R&D, Chief Scientific Off gave up 10,053 shares (to pay taxes)
- 4 Shares withheld for taxes EVP-Technical Operations gave up 10,053 shares (to pay taxes)
- 4 Shares withheld for taxes Exec. Vice Pres. HR gave up 1,191 shares (to pay taxes)
- 4 Shares withheld for taxes CEO & President gave up 39,391 shares (to pay taxes)
- 4 Shares withheld for taxes Exec VP Finance, CFO gave up 9,446 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes Exec VP Finance, CFO gave up 4,157 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes CEO & President gave up 10,635 shares (to pay taxes)
- 4 Shares withheld for taxes Exec VP Finance, CFO gave up 1,063 shares (to pay taxes)
Page 9 of 28 · 560 filings